Clinical Laserthermia Systems AB 

€0.41
0
+€0.06+17.43% Thursday 06:14

Statistics

Day High
0.41
Day Low
0.41
52W High
1.04
52W Low
0.18
Volume
-
Avg. Volume
-
Mkt Cap
10.56M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

20FebExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-219.37%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.74MRevenue
-10.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LS60.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc offers a range of medical technologies, including surgical products that compete with CLS's laser ablation technologies used in surgical procedures.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical, Inc. provides robotic-assisted surgical systems that can be used in procedures where CLS's laser therapies might also be applicable.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation manufactures medical devices used in various interventional medical specialties, competing with CLS in the area of minimally invasive surgeries.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson engages in the development of medical devices, including surgical systems that could be used in similar applications as CLS's laser treatment products.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that compete with CLS's offerings.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products, some of which may overlap with the surgical applications of CLS's technologies.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie Inc. develops and markets advanced medical treatments, including technologies that could compete with CLS's therapeutic laser systems in certain healthcare applications.
Baxter International
BAX
Mkt Cap8.61B
Baxter International Inc. produces medical devices and pharmaceuticals that can be used in critical and chronic care, potentially competing with CLS's laser-based treatments.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences Corporation specializes in heart valve therapy and critical care products, which may compete with CLS in specific surgical applications involving laser technologies.

About

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Show more...
CEO
Mr. Dan Johansson Mogren
Employees
13
Country
SE
ISIN
SE0022049920
WKN
000A403UF

Listings

0 Comments

Share your thoughts

FAQ

What is Clinical Laserthermia Systems AB stock price today?
The current price of LS60.F is €0.41 EUR — it has increased by +17.43% in the past 24 hours. Watch Clinical Laserthermia Systems AB stock price performance more closely on the chart.
What is Clinical Laserthermia Systems AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clinical Laserthermia Systems AB stocks are traded under the ticker LS60.F.
Is Clinical Laserthermia Systems AB stock price growing?
LS60.F stock has risen by +11.99% compared to the previous week, the month change is a -11.42% fall, over the last year Clinical Laserthermia Systems AB has showed a +124.34% increase.
What is Clinical Laserthermia Systems AB market cap?
Today Clinical Laserthermia Systems AB has the market capitalization of 10.56M
What is Clinical Laserthermia Systems AB revenue for the last year?
Clinical Laserthermia Systems AB revenue for the last year amounts to 4.74M EUR.
What is Clinical Laserthermia Systems AB net income for the last year?
LS60.F net income for the last year is -10.4M EUR.
How many employees does Clinical Laserthermia Systems AB have?
As of April 10, 2026, the company has 13 employees.
When did Clinical Laserthermia Systems AB complete a stock split?
The last stock split for Clinical Laserthermia Systems AB was on April 25, 2024 with a ratio of 1:200.
Where is Clinical Laserthermia Systems AB headquartered?
Clinical Laserthermia Systems AB is headquartered in Lund, SE.